Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)

Diego Franciotta, Matteo Gastaldi, Arianna Sala, Francesca Andreetta, Elena Rinaldi, Maddalena Ruggieri, Rosaria Leante, Gianna Costa, Tiziana Biagioli, Luca Massacesi, Elena Bazzigaluppi, Raffaella Fazio, Sara Mariotto, Sergio Ferrari, Elisabetta Galloni, Francesco Perini, Elisabetta Zardini, Luigi Zuliani, Marco Zoccarato, Bruno GiomettoAntonio Bertolotto

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

This document presents the guidelines for anti-aquaporin-4 (AQP4) antibody testing that has been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on neuromyelitis optica spectrum disorders, indications and limits of anti-AQP4 antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.

Original languageEnglish
Pages (from-to)231-236
Number of pages6
JournalNeurological Sciences
Volume38
DOIs
Publication statusPublished - Oct 1 2017

Fingerprint

Aquaporin 4
Neuromyelitis Optica
Antibodies
Internet
Guidelines
Education
Pathologists
Neurologists
Surveys and Questionnaires

Keywords

  • Anti-aquaporin-4 antibodies
  • Anti-myelin oligodendrocyte glycoprotein antibodies
  • Cell-based assay
  • Laboratory diagnostics
  • Neurological autoimmune diseases

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). / Franciotta, Diego; Gastaldi, Matteo; Sala, Arianna; Andreetta, Francesca; Rinaldi, Elena; Ruggieri, Maddalena; Leante, Rosaria; Costa, Gianna; Biagioli, Tiziana; Massacesi, Luca; Bazzigaluppi, Elena; Fazio, Raffaella; Mariotto, Sara; Ferrari, Sergio; Galloni, Elisabetta; Perini, Francesco; Zardini, Elisabetta; Zuliani, Luigi; Zoccarato, Marco; Giometto, Bruno; Bertolotto, Antonio.

In: Neurological Sciences, Vol. 38, 01.10.2017, p. 231-236.

Research output: Contribution to journalReview article

Franciotta, D, Gastaldi, M, Sala, A, Andreetta, F, Rinaldi, E, Ruggieri, M, Leante, R, Costa, G, Biagioli, T, Massacesi, L, Bazzigaluppi, E, Fazio, R, Mariotto, S, Ferrari, S, Galloni, E, Perini, F, Zardini, E, Zuliani, L, Zoccarato, M, Giometto, B & Bertolotto, A 2017, 'Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)', Neurological Sciences, vol. 38, pp. 231-236. https://doi.org/10.1007/s10072-017-3027-1
Franciotta, Diego ; Gastaldi, Matteo ; Sala, Arianna ; Andreetta, Francesca ; Rinaldi, Elena ; Ruggieri, Maddalena ; Leante, Rosaria ; Costa, Gianna ; Biagioli, Tiziana ; Massacesi, Luca ; Bazzigaluppi, Elena ; Fazio, Raffaella ; Mariotto, Sara ; Ferrari, Sergio ; Galloni, Elisabetta ; Perini, Francesco ; Zardini, Elisabetta ; Zuliani, Luigi ; Zoccarato, Marco ; Giometto, Bruno ; Bertolotto, Antonio. / Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). In: Neurological Sciences. 2017 ; Vol. 38. pp. 231-236.
@article{8fbc701768594a9899ede9ae76c91504,
title = "Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)",
abstract = "This document presents the guidelines for anti-aquaporin-4 (AQP4) antibody testing that has been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on neuromyelitis optica spectrum disorders, indications and limits of anti-AQP4 antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.",
keywords = "Anti-aquaporin-4 antibodies, Anti-myelin oligodendrocyte glycoprotein antibodies, Cell-based assay, Laboratory diagnostics, Neurological autoimmune diseases",
author = "Diego Franciotta and Matteo Gastaldi and Arianna Sala and Francesca Andreetta and Elena Rinaldi and Maddalena Ruggieri and Rosaria Leante and Gianna Costa and Tiziana Biagioli and Luca Massacesi and Elena Bazzigaluppi and Raffaella Fazio and Sara Mariotto and Sergio Ferrari and Elisabetta Galloni and Francesco Perini and Elisabetta Zardini and Luigi Zuliani and Marco Zoccarato and Bruno Giometto and Antonio Bertolotto",
year = "2017",
month = "10",
day = "1",
doi = "10.1007/s10072-017-3027-1",
language = "English",
volume = "38",
pages = "231--236",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)

AU - Franciotta, Diego

AU - Gastaldi, Matteo

AU - Sala, Arianna

AU - Andreetta, Francesca

AU - Rinaldi, Elena

AU - Ruggieri, Maddalena

AU - Leante, Rosaria

AU - Costa, Gianna

AU - Biagioli, Tiziana

AU - Massacesi, Luca

AU - Bazzigaluppi, Elena

AU - Fazio, Raffaella

AU - Mariotto, Sara

AU - Ferrari, Sergio

AU - Galloni, Elisabetta

AU - Perini, Francesco

AU - Zardini, Elisabetta

AU - Zuliani, Luigi

AU - Zoccarato, Marco

AU - Giometto, Bruno

AU - Bertolotto, Antonio

PY - 2017/10/1

Y1 - 2017/10/1

N2 - This document presents the guidelines for anti-aquaporin-4 (AQP4) antibody testing that has been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on neuromyelitis optica spectrum disorders, indications and limits of anti-AQP4 antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.

AB - This document presents the guidelines for anti-aquaporin-4 (AQP4) antibody testing that has been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on neuromyelitis optica spectrum disorders, indications and limits of anti-AQP4 antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.

KW - Anti-aquaporin-4 antibodies

KW - Anti-myelin oligodendrocyte glycoprotein antibodies

KW - Cell-based assay

KW - Laboratory diagnostics

KW - Neurological autoimmune diseases

UR - http://www.scopus.com/inward/record.url?scp=85032855606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032855606&partnerID=8YFLogxK

U2 - 10.1007/s10072-017-3027-1

DO - 10.1007/s10072-017-3027-1

M3 - Review article

AN - SCOPUS:85032855606

VL - 38

SP - 231

EP - 236

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -